Established 1999
     
8,000 companies from USA and India.  
   
Search over 25,500 news articles and 8,000 companies earnings    


Gilead Sciences, Inc. (GILD)
$51.87 -0.59 (-1.12%)   May 15

333 Lakeside Drive , Foster City,  CA  94404 , USA
+1-650-574-3000
  http://www.gilead.com
PRICES
VALUATIONS
RATIOS
STOCKHOLDERS
Open
Volume
Mkt Cap

P/E
EPS (prev. yr)
Dividend
Yield
52.31
6.05M
41600

14.61
3.55
n/a
n/a
High
Low
52wk    High
52wk
Low
BV
P/BV
Outstanding Shares

52.36
51.67
56.03
35.34
7.63
6.80
802.00

You need to upgrade your Flash Player
Chart Type: Line - Basic Comparison OHLC Candlestick Smooth


amcolumn
You need to upgrade your Flash Player


You need to upgrade your Flash Player

Financial Summary (In millions of USD)
2003
2004
2005
2006
2007
2008
2009
2010
Income Statement
Total Revenue
$867.86
$1,324.62
$2,028.40
$3,026.14
$4,230.05
$5,335.75
$7,011.38
$7,949.42
Operating Income
$-158.68
$627.39
$1,111.10
$-758.75
$2,164.51
$2,678.54
$3,529.22
$3,962.22
Net Income
$-72
$449.37
$813.91
$-1,189.96
$1,615.30
$1,978.90
$2,635.76
$2,901.26
Balance Sheet
Total Assets
$1,554.72
$2,155.96
$3,766.32
$4,085.98
$5,834.72
$7,018.57
$9,698.56
$11,592.63
Total Equity
$1,002.97
$1,870.87
$3,027.78
$1,815.72
$3,459.99
$4,152.49
$6,367.06
$6,121.84
Total Liabilities
$551.75
$285.09
$738.54
$2,270.26
$2,374.73
$2,866.09
$3,331.49
$5,470.79
Cash Flow
Operating
$234.61
$507.96
$705.64
$1,218.06
$1,765.40
$2,204.66
$2,143.38
$3,080.05
Investing
$-727.35
$-487.41
$-682.48
$-1,739.33
$-1,302.47
$-178.82
$-178.82
$-2,215.90
Financing
$82.09
$78.66
$441.90
$649.26
$-267.30
$-1,535.84
$-1,474.57
$-1,051.44
Net Cash Change
$-422.21
$86.19
$427
$108.09
$152.08
$491.22
$491.22
$-186.34

Earnings Calls Calendar
2010
2009
2008
2007
2006
26 January 2010
20 April 2010
20 July 2010
19 October 2010
27 January 2009
21 April 2009
21 July 2009
20 October 2009
23 January 2008
16 April 2008
17 July 2008
16 October 2008
31 January 2007
12 March 2007
18 April 2007
13 June 2007
19 July 2007
18 October 2007
18 April 2006
20 July 2006
18 October 2006

Earnings Calls Summary
 Transcripts

10K Reports
 Annual Reports

123Jump News
02 October 2006 1:04 PM
Harrah's to Be Bought for $15 B
02 October 2006 12:09 PM
Wal-Mart Sales Weigh
02 October 2006 10:06 AM
Gilead Takes Over Myogen for $2.5 B
02 October 2006 9:01 AM
Biotechs Set to Score Gains
16 August 2003
Biotechs Set to Score Gains
15 August 2003
JP Morgan Meet Puts Biotechs in the Spotlight
20 January 2003
Biotech Sector: Consolidation on Cards
16 December 2002
Pharmas and Biotechs Get Booster Shots
13 November 2002
Biotech Prospects to Brighten by Year End
10 October 2002
More...

Management
Executive
Title
James M. Denny
Chairman of the Board
John C. Martin
President, Chief Executive Officer and Director
Michael J. Gerber
Senior Vice President - Clinical Research
Paul Carter
Senior Vice President - International Commercial Operations
Anthony D. Caracciolo
Senior Vice President of Manufacturing and Operations
Gregg H. Alton
Senior Vice President and General Counsel
Kevin Young
Executive Vice President - Commercial Operations
Norbert W. Bischofberger
Executive Vice President - Research and Development and Chief Scientific Officer
John F. Milligan
Chief Financial Officer, Chief Operating Officer and Executive Vice President
William A. Lee
Senior Vice President - Research


Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites.
Market data: BATS Exchange. Inc.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
Other Sites:
© 1999-2012 123jump.com. All rights reserved